Laboratory:Akiruno
- TOP
- pathological test
- histopathological test
- Lung cancer PD-L1 protein (IHC)22C3
Laboratory:Akiruno
○Lung cancer PD-L1 protein (IHC)22C3
CODE:06269 7
-
TEST NAME
SPECIMEN SUBMISSION
SPECIMEN
REQUIREMENT
CONTAINER CAP COLOR STORE
TEMPERATURE
(STABILITY) TURNAROUND
TIME (DAY) METHODOLOGY -
Lung cancer PD-L1 protein (IHC)22C3
Unstained specimen slide 4 unstained slide specimens Z10
5-8 Immunohistochemical staining method
COMMENT
How to submit lung cancer PD-L1 protein (IHC) 22C3
1) Since the presence or absence of cancer cells may be unknown, please attach a copy of the pathological diagnosis when requesting the test. (However, it is not necessary if our company conducts general pathological examinations.) If it is not possible to attach it for various reasons, please include the name of the pathological diagnosis (tissue type, etc.) in the request form, as well as clinical information to the extent possible. Please fill in the form below.
2) The material is an unstained specimen slide (made from a formalin-fixed paraffin block) of lung cancer (primary tumor or metastatic tumor). Please use slides coated with silane, etc., and after slicing, dry overnight at approximately 40℃ before submitting.
3) Slice the tissue to a thickness of 4 to 5 μm and attach it as close to the center as possible, keeping it at least 15 mm from the edge of the frost and at least 15 mm from the edge of the glass slide.
4) If you request paraffin blocks, there will be a delay in the number of days required to prepare unstained slides, so please check with our sales staff.
Please use slides coated with silane, etc., and dry them overnight at approximately 40°C after slicing before submitting. Slice the tissue to a thickness of 4 to 5 μm and attach it as close to the center as possible, at least 15 mm from the edge of the frost and 15 mm from the edge of the glass slide.
CONTAINER
Z10 旧容器記号 t 30
[オブジェクトケース]
プレパラート (スライドグラス)
貯蔵方法:室温
supplementary information
肺癌 PD-L1タンパク (IHC) 22C3 の注意事項
判定基準 TPS(%) 判定 0 陰性 1-49 発現あり 50以上 高発現 -
ペムブロリズマブの投与基準
(試薬添付文書より)対象患者 投与基準 既治療 非小細胞肺癌 TPSが1%以上 未治療 非小細胞肺癌 TPSが50%以上